Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · IEX Real-Time Price · USD
0.800
-0.015 (-1.90%)
At close: Jul 2, 2024, 4:00 PM
0.818
+0.018 (2.25%)
After-hours: Jul 2, 2024, 6:22 PM EDT
Karyopharm Therapeutics Stock Forecast
KPTI's stock price has decreased by -53.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KPTI stock have an average target of 4.60, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 475.00% from the current stock price of 0.80.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KPTI stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +775.00% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +900.00% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +900.00% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +900.00% | Mar 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +525.00% | Nov 3, 2023 |
Financial Forecast
Revenue This Year
147.77M
from 146.03M
Increased by 1.19%
Revenue Next Year
167.20M
from 147.77M
Increased by 13.15%
EPS This Year
-1.24
from -1.25
EPS Next Year
-0.91
from -1.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 156.2M | 220.2M | 277.1M | 447.6M | 565.1M |
| Avg | 147.8M | 167.2M | 227.1M | 343.9M | 406.7M |
| Low | 137.3M | 127.5M | 164.6M | 246.8M | 293.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.9% | 49.0% | 65.7% | 97.1% | 64.3% |
| Avg | 1.2% | 13.1% | 35.8% | 51.5% | 18.2% |
| Low | -6.0% | -13.7% | -1.5% | 8.7% | -14.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.21 | -0.60 | -0.46 | 0.65 | 0.32 |
| Avg | -1.24 | -0.91 | -0.58 | -0.03 | 0.04 |
| Low | -1.29 | -1.23 | -0.67 | -0.38 | -0.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.